• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. VICRYL POLYGLACTIN 910 SUTURE; SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. VICRYL POLYGLACTIN 910 SUTURE; SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID Back to Search Results
Catalog Number J359
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/11/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Product complaint :(b)(4).Date sent to the fda: 5/12/2025.H6 component code: g07002 - device not returned this report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.(b)(4): the thread broke twice.- were there any adverse consequences associated with the patient? no patient consequences.- when was the thread broke (in the package, during removal from package, during handling prior to use on patient or during use on the patient)? please specify: during use on the patient.(b)(4): represents the ambiguous number of events.- were there any adverse consequences associated with the patient? no patient consequences, use of a third suture.- what is the total number of procedures? several cases of breakage (needle or detachment of the thread) recently (case on (b)(6) 2024, two cases on (b)(6) 2025) and each time with vicryl but from different references, but no breakage of the thread yet.The pharmacist has no additional information.The doctor who noted the defect is absent until may and will get back to us with a more detailed description of the facts the two cases on february 2025 are (b)(4) and the case on (b)(6) 2024 is (b)(4).To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.D4: udi: the expiration date is currently not available.Therefore, the full udi is currently not available.The following information was requested: the reported lot udbcznhd0 is invalid, please confirm the lot number.
 
Event or Problem Description
It was reported that a patient underwent an c-section procedure on (b)(6) 2025 and suture was used.A surgical nurse "ibode" reported a quality defect regarding the use of a suture.During a uterine suture following a cesarean section using vicryl 1, the thread broke twice.This is not the first time this has happened.There were no patient consequences reported.Additional information was requested.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Date sent to the fda: 6/10/2025.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Corrected information: d4 (lot).The following information was requested: the correct lot n° is udbczhd0.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Date sent to the fda: 7/8/2025 this report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VICRYL POLYGLACTIN 910 SUTURE
Common Device Name
SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.-GMBH
robert-koch strasse 1
p.o. box 1409
norderstedt
GM  
Manufacturer Contact
orla o'mahony
1000 route 202
raritan, NJ 08869
3035526892
MDR Report Key22004826
Report Number2210968-2025-05228
Device Sequence Number13040201
Product Code GAM
UDI-Device Identifier10705031039278
UDI-Public10705031039278
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K022269
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date (Section B) 05/12/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberJ359
Device Lot NumberUDBCZHD0
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/14/2025
Supplement Date Received by Manufacturer05/13/2025
06/12/2025
Initial Report FDA Received Date05/12/2025
Supplement Report FDA Received Date06/10/2025
07/08/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured04/22/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-